Posttreatment changes with rosuvastatin ( @ mg/d ) in plasma ceramides were inversely associated with VLDL apoB-@ FCR ( r = -@ , P = @ ) independent of changes in plasma triglycerides , cholesterol , and low-density lipoprotein-cholesterol .